Browse the evidence

In males with type 2 diabetes, higher baseline endogenous total testosterone and lower estradiol levels significantly enhance the reduction of triglycerides achieved through intensive lifestyle intervention.

If you are a man with type 2 diabetes, your baseline testosterone and estradiol levels may dictate how effectively your diet and exercise efforts lower triglycerides. Men with higher testosterone and lower estradiol tend to see bigger improvements in triglycerides from lifestyle changes. This suggests that knowing your hormone profile could help tailor your lifestyle prescription for better lipid outcomes.

In females with type 2 diabetes, higher baseline sex hormone-binding globulin (SHBG) significantly enhances the reduction of LDL cholesterol achieved through intensive lifestyle intervention.

If you are a postmenopausal woman with type 2 diabetes, your baseline SHBG levels may dictate how effectively your diet and exercise efforts lower LDL cholesterol. Women with higher SHBG tend to see bigger improvements in LDL-C from lifestyle changes. This suggests that knowing your hormone profile could help tailor your lifestyle prescription for better lipid outcomes.

Higher baseline total testosterone predicts greater long-term weight loss and waist circumference reduction in both males and females with type 2 diabetes undergoing intensive lifestyle intervention.

If you have type 2 diabetes, your baseline testosterone levels may dictate how effectively your diet and exercise efforts lead to weight loss and waist circumference reduction. Both men and women with higher testosterone tend to see bigger improvements in weight and waist size from lifestyle changes. This suggests that knowing your hormone profile could help tailor your lifestyle prescription for better weight outcomes.

Elevated diabetes-related emotional distress is significantly associated with poorer glycemic control, even among patients who otherwise maintain medication adherence.

Recognize that emotional stress about diabetes can directly worsen blood sugar levels. If you feel distressed, discuss it with your healthcare team. Managing your mental health is as important as managing your diet and medication for achieving good glycemic control.

Lower socioeconomic status is significantly associated with poorer glycemic control in urban Indian patients with Type 2 Diabetes.

Financial and social factors play a significant role in blood sugar control. If cost is a barrier, discuss this with your doctor. They may be able to suggest lower-cost alternatives or connect you with resources to help manage your diabetes.

Metabolic bariatric surgery leads to sustained HbA1c reduction, whereas non-surgical management is associated with HbA1c increase in patients with type 2 diabetes.

For patients with severe obesity and type 2 diabetes, metabolic bariatric surgery offers significantly better long-term weight loss and blood sugar control than non-surgical management. While surgery is not for everyone, those who undergo it maintain much greater weight loss (22% vs 8.6%) and better glycemic control over five years. If surgery is not an option, intensive lifestyle modification and pharmacotherapy are critical alternatives to mitigate health risks.

Bariatric surgery (RYGB, SG, LAGB, BPD) significantly improves Type 2 Diabetes (T2DM) remission and lowers HbA1c levels compared to medical/lifestyle management (MT) in mid- to long-term follow-up.

For individuals with Type 2 Diabetes and obesity, bariatric surgery (specifically RYGB, SG, LAGB, or BPD) is significantly more effective than medical management or lifestyle changes alone for achieving diabetes remission and lowering HbA1c levels over the long term. While surgery carries risks and requires lifelong monitoring, it offers a superior path to metabolic health compared to non-surgical approaches for this population.

Roux-en-Y Gastric Bypass (RYGB) is the most favorable option for managing BMI and triglyceride (TG) levels in the mid-term, and is the second-best option for T2DM remission.

Roux-en-Y Gastric Bypass (RYGB) is a highly effective and well-studied surgical option for managing Type 2 Diabetes, particularly for improving BMI and triglyceride levels. It offers significant benefits for metabolic health and is a favorable choice for patients seeking a balance between efficacy and established surgical data.

Achieving comprehensive metabolic control (simultaneous HbA1c, LDL-C, and blood pressure targets) significantly reduces the risk of cardiovascular and microvascular complications in diabetic patients.

For diabetic patients, managing blood sugar, blood pressure, and cholesterol together is critical. Missing any one target leaves you at higher risk for heart and kidney damage. Work with your doctor to hit all three goals simultaneously, not just one.

High socioeconomic status, structured education (>6 sessions), therapeutic adherence, and frequent self-monitoring of blood glucose (>4/day) are independent predictors of achieving optimal metabolic control in diabetes.

To get the best results from your diabetes treatment, you need more than just pills. You need to take them consistently, monitor your blood sugar frequently (more than 4 times a day), and engage in structured education. If you have financial or social barriers, seek support, as these factors significantly impact your ability to control your blood sugar.

Probiotic and synbiotic supplementation improves glycemic control, lipid profiles, and reduces inflammation in patients with type 2 diabetes and obesity, with strain-specific effects.

Taking specific probiotic or synbiotic supplements daily can modestly improve blood sugar and cholesterol levels in people with diabetes or obesity. Choose strains with clinical evidence (like Lactobacillus acidophilus or Bifidobacterium lactis) and take them consistently for at least 12 weeks.

Broadening obesity treatment goals beyond weight loss to include obesity-related diseases, health-related quality of life (HrQoL), body image, and weight bias internalization (WBI) improves patient-centered care and treatment adherence.

When starting obesity treatment, discuss your goals beyond just weight loss. Ask your provider about improvements in energy, pain, mood, or disease markers. If you are motivated by appearance, be open about this so your care team can address body image concerns proactively, which may include counseling. This helps ensure the treatment plan aligns with what matters most to you, increasing your chances of sticking with it.

Visceral fat accumulation is a primary driver of cardiovascular disease in obesity, independent of BMI, through inflammatory and metabolic mechanisms.

Focus on reducing visceral fat through lifestyle changes, not just BMI. Even if your BMI is normal, high waist circumference indicates higher cardiovascular risk.

Energy restriction, rather than carbohydrate restriction itself, is the primary driver of adverse symptoms (keto-flu) during the induction phase of low-carbohydrate diets.

If you experience 'keto-flu' or withdrawal symptoms, check your calorie intake first. You may be eating too little. Ensuring energy sufficiency can reduce these symptoms more effectively than adjusting carb levels alone.

In older Chinese adults, a vegetable-based low-carbohydrate diet (high-quality carbs, plant protein, unsaturated fat) is associated with higher all-cause and cardiovascular disease mortality, whereas a meat-based low-carbohydrate diet (low-quality carbs, animal protein, saturated fat) is associated with lower mortality.

If you are following a low-carbohydrate diet, pay close attention to the source of your carbohydrates and fats. In older adults, particularly those with Asian dietary backgrounds, a vegetable-based low-carb diet (high in plant proteins and unsaturated fats) was associated with higher mortality, while a meat-based low-carb diet (higher in animal proteins and saturated fats) was associated with lower mortality. This suggests that simply reducing carbohydrates is not enough; the quality and source of the remaining macronutrients are critical. Consult with a healthcare provider to tailor your diet to your specific health profile and cultural context.

Low-carbohydrate diets are effective for short-term glycemic control (3-6 months) in type 2 diabetes, reducing HbA1c more than higher-carbohydrate diets, but this benefit is not maintained at 12 months.

If you have type 2 diabetes, reducing carbohydrates can help lower your blood sugar levels in the first few months. However, this effect tends to fade after a year, so it is not a permanent fix on its own. It is best used as part of a broader strategy that includes weight management and food quality.

Low-carbohydrate diets (LCD) and low-fat diets (LFD) are similarly effective for weight loss and reducing hepatic fat in NAFLD patients, with no clear clinical superiority of one over the other.

You can choose either a low-carb or low-fat diet to manage NAFLD; both are effective for reducing liver fat and weight. Focus on consistency and adherence rather than debating which macronutrient is superior.

Low-carbohydrate diets (LCD) and low-fat diets (LFD) produce statistically similar long-term weight loss, although LCDs yield faster initial loss.

If you are choosing between low-carb and low-fat for weight loss, expect similar results after one year. Low-carb might help you drop weight faster in the first few months, but low-fat is often easier to sustain socially and culturally. Choose the one you can stick to long-term, as the long-term weight loss difference is negligible.

Low-carbohydrate diets improve triglycerides and HDL more effectively than low-fat diets, while low-fat diets are more effective at reducing LDL cholesterol.

If your main issue is high triglycerides or low HDL, a low-carb diet may improve your heart health markers more than a low-fat diet. If your main issue is high LDL cholesterol, a low-fat diet might be more effective for that specific number. Consult a professional to interpret your full lipid panel.

High-carbohydrate overfeeding induces the greatest increase in 24-hour energy expenditure (EE) compared to other macronutrient compositions, while substrate oxidation shifts (e.g., fat vs. carbohydrate) are primarily driven by the availability of the ingested macronutrient.

If you are overfeeding, eating a high-carbohydrate diet will boost your daily energy expenditure more than high-fat or high-protein diets of the same caloric excess. Furthermore, your body will primarily oxidize the macronutrient you just ate (carbs for carb diets, fat for fat diets), rather than forcing a specific fuel source regardless of intake. This suggests that macronutrient composition is a key lever for managing metabolic rate and fuel selection during overfeeding.

Circulating acylcarnitine levels and glycerophospholipid changes serve as reliable metabolic markers for substrate oxidation preference (measured by Respiratory Quotient) during nutritional interventions.

Current research suggests that blood levels of specific metabolites (like carnitines and phospholipids) can predict how your body prefers to burn fuel (fat vs. carbs). While not yet a standard clinical tool, this points to a future where simple blood tests could help tailor diets to your specific metabolic phenotype, rather than using a one-size-fits-all approach.

Higher neighborhood-level availability of calories, carbohydrates, total fat, and saturated fat is positively associated with increased odds of being overweight in adults.

Your local food environment significantly impacts your weight risk. If you live in an area with high-calorie, high-fat food options, your odds of being overweight increase. To mitigate this, prioritize living in or visiting areas with more green space and lower saturated fat contributions, and be aware that 'healthy' labels on outlets may not reflect actual macronutrient content.

Endoscopic interventions such as Endoscopic Sleeve Gastroplasty (ESG) and Transoral Outlet Reduction (TORe) are effective minimally invasive treatments for managing post-bariatric recurrent weight gain (RWG).

If you are gaining weight back after bariatric surgery, ask your doctor about endoscopic procedures like ESG or TORe. These are minimally invasive options that can help with weight loss without the risks of major surgery. They work by mechanically restricting your stomach or outlet size. While they are not as effective as GLP-1 drugs in some cases, they are a valuable tool for managing RWG.

Long-term adherence to a high-quality low-carbohydrate diet (HQ-LCDS) is associated with favorable changes in HDL cholesterol and triglycerides, whereas a low-quality low-carbohydrate diet (LQ-LCDS) is associated with adverse changes in fasting glucose.

If you follow a low-carbohydrate diet, ensure the carbohydrates you do eat are high-quality (high fiber, whole foods). Avoid replacing healthy carbs with refined grains or added sugars, as this can negatively impact blood glucose levels. Prioritizing high-quality carbs in your low-carb pattern improves HDL and lowers triglycerides.